Skip to content

Clinical trials

Primary Myelofibrosis trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Country / region: Sweden Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20131
20151
20161
20171
20193
20204
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting4
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Novartis Pharmaceuticals4
Sierra Oncology LLC - a GSK company2
CTI BioPharma1
Celgene1
European Organisation for Research and Treatment of Cancer - EORTC1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
John Mascarenhas1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis16
Neoplasms5
Myeloproliferative Disorders3
Polycythemia Vera3
Anemia2
Leukemia, Myeloid, Acute2
Leukemia, Myelomonocytic, Chronic2
Thrombocythemia, Essential2
Blast Crisis1
Bone Marrow Diseases1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.